7.15 AM onwards

REGISTRATION

7.45-8.15 AM

BUMPER QUIZ

8.15-8.45 AM

Session 17 - Dr. J. G. Parekh Oration(Hall A)

Chairperson: Dr. Nabanita Chakraborty & Dr. T. K.Dutta

Topic: Identification of new targets and biomarkers for Multiple Myeloma
using Proteomic and Metabolomics approaches

Speaker - Dr Tathagata Chatterjee

8.45 - 10.00 AM

8:45 - 9:10 AM

Haemophilia with inhibitors-Diagnosis and pitfalls.

Speaker: Dr. Tulika Seth

Myelofibrosis: assessing prognosis.

Speaker: Dr. M. B. Agarwal

Tools for MRD detection.

Speaker: Dr. Deepak K Mishra

Mantel Cell Lymphoma: Diagnostic issues.

Speaker: Dr. Saumyaranjan Mallick

9:10 -9:35 AM

Changing landscape in Haemophilia prophylaxis.

Speaker: Dr. Philip Kuriakose

Myelofibrosis: Symptom directed management.

Speaker: Dr. Uday Yanamandra

Update on MRD in AML: Are we in a position to decide further therapy?

Speaker: Dr. Ashish Dixit

Frontline management of MCL: Indian Perspective.

Speaker: Dr. Reena Nair

9:35 - 10:00 AM

Haemophilia gene therapy: Optimisms and questions.

Speaker: Dr. Prakas Kumar Mandal

Myelofibrosis: Ruxolitimib and beyond

Speaker: Dr. Manoranjan Mahapatra

MRD in MM: Current status.

Speaker: Dr. K S Nataraj

Role of Novel agents in treatment of MCL.

Speaker: Dr. Priyanka Pophali

10.00-10.25 AM

Session 22

Chairpersons: Dr. Somanath Padhi & Dr. Preeti Tripathi

A Systems Approach to Blood Disorders-an update from National Heart, Lung, and Blood Institute (NHLBI)

Speaker : Dr Pankaj Qasba, Program Director

Session 23

Chairpersons: Dr. D. K. Mishra & Dr. Pushkar Admane

Sherlock Holming in haematology:resurrection of diagnostic morphology

Speaker : Dr. Vishal Jayakar

Session 24

Chairpersons: Dr. Krishna Basu & Dr. Soumitro Ghosh

Topic - Chronic myeloid leukemia: Challenges and ahead

Speaker : Dr. Tusti Ganguly

Session 25

Chairpersons: Dr. Gaurav Chhabra & Dr Sanjay Gohil

Manufacturing of Car T Products –an overview

Speaker : Dr. Rizwan Javed

10.25-10.55 AM

Coffee Break

10.55-12.25 PM

Session 26-ISHBT-ASH Joint Symposium (Hall A)

Topic: Sickle Cell Disease

Chairpersons: Dr. Haraprasad Pati & Dr. Mohandas Narla

Topic: Practical Management and outcome of SCD

Speaker: Dr. Mohandas Narla

Topic: Role of gene therapy in SCD

Speaker: Dr. Alexis A.Thompson

Topic: Sickle cell disease in India - How it different from west?

Speaker: Dr. R. K. Jena

12.25-1.25 PM

1.25-2.00 PM

Lunch Break with Poster Walk

2.00-3.00 PM

2.00 PM - 2.12 PM

Role of granulocyte transfusions in hematopoietic stem cell transplantation: Experience from a tertiary care hospital in North India

Speaker: Dr. Sanjeev

Authorship diversity in haematology-related Cochrane systematic reviews: Inequities in global representation

Speaker: Dr. Arkadeep Dhali

Upfront combined hydroxyurea and imatinib versus imatinib monotherapy in newly diagnosed chronic phase chronic myeloid leukaemia patients with reference to early molecular response: A randomized controlled trial

Speaker: Dr. Rituparna Chetia

Standardization of digital droplet PCR (DDPCR) for T(8;21) RUNX1::RUNX1T1 MRD monitoring in acute myeloid leukemia

Speaker: Dr. Poonam Das

2.13 PM - 2.24 PM

Quinolone prophylaxis and carbapenem-resistant infection in patients undergoing hematopoietic stem cell transplant

Speaker: Dr. Rahul Naithani

Automation vs. manual platelet count- An audit of a real-life scenario in a tertiary care centre in India

Speaker: Dr. Ankita Dewangan

Validation of ELN 2022 risk stratification system for acute myeloid leukemia patients- In comparison with ELN 2017 from a tertiary care centre

Speaker: Dr. Ramesh Balasubramanian

Clinical utility of CD177 in the diagnosis of myelodysplastic syndrome

Speaker: Dr. Denna Sarah Prabhin

2.25 PM - 2.36 PM

Role of microRNA in hydroxyurea mediated HBF induction in sickle cell anaemia patients

Speaker: Dr. Neha Kargutkar

Exploring the alterations in erythrocytes and haemoglobin in women with PCOS: A follow up study

Speaker: Dr. Ipsita Chakraborty

Randomised controlled study to compare toxicity profile of dexamethasone versus prednisolone in induction phase chemotherapy in pediatric & adolescent ALL

Speaker: Dr. Karthik Kumar

Correlation between flow cytometric expression of CRLF2 and FISH rearrangement of CRLF2: A study of 30 cases from tertiary cancer centre in North East

Speaker: Dr. Karthik R

2.37 PM - 2.48 PM

Experience of ITI therapy for hemophilia patients from a tertiary care center of Eastern India: A one-year follow up

Speaker: Dr. Prerna Pramanik

Reticulocyte haemoglobin equivalent as a potential marker for diagnosis and treatment response of iron deficiency anaemia

Speaker: Dr. Manali Satiza

Indian multicenter phase II randomised controlled study comparing post stem cell maintenance regimen for newly diagnosed multiple myeloma (Impose bortecon study)

Speaker: Dr. Uday Yanamandra

Prospective analysis of the genomic landscape of ‘B-other ALL’ and its impact on clinical outcome: Data from a single tertiary cancer care centre in India

Speaker: Dr. Purvi Mohanty

2.49 PM - 3.00 PM

Concizumab prophylaxis in patients with haemophilia A or B with inhibitors: Efficacy and safety results from the primary analysis of the phase 3 explorer7 trial

Speaker: Dr. Chetna Kaushik

Flow cytometric estimation of platelet derived microparticles isolated by sedimentation and centrifugation protocols in chronic diseases: A comparative study

Speaker: Dr. Shagun Wadhwa

Hodgkin lymphoma: Experience with PET guided de-escalation of therapy in real world

Speaker: Dr. Akshay Lahoti

Validation of NGS based RNA fusion sequencing in myeloid neoplasm: A single center experience.

Speaker: Dr. Kallol Saha

3.00-4.15 PM

3.00-3.25 PM

Fanconi Anaemia: Diagnostic modalities.

Speaker: Dr. Mayur Parihar

Abnormal blood counts: Is the patient fit for surgery?

Speaker: Dr. Vijay Kumar

Quality control in the coagulation lab.

Speaker: Dr. Ankur Kumar Lath

Allogeneic SCT: The week after engraftment is vital.

Speaker: Dr. Nitin Gupta

3.25-3.50 PM

PNH clone Aplastic Anaemia: How to tackle.

Speaker: Dr. Saroj Bala

Thrombocytopenia in OPD: Etiology and counselling.

Speaker: Dr. Amrita Saraf

Approach to bleeding disorder in children.

Speaker: Dr. Seema Tyagi

Role of Haplotransplant in severe AA.

Speaker: Dr. Ganesh Jaishetwar

3.50-4.15 PM

AA: Current Concepts in Marrow Failure Syndromes

Speaker: Dr. Phillip Scheinberg

Management of liver disease-related bleeding.

Speaker: Dr. Avinash Pophali

Rare bleeding disorders: Case based discussions.

Speaker: Dr. Chandrakala Shanmukhaiah

Transplant in non-malignant disorder.

Speaker: Dr. Kundan Mishra

4.15-4.45 PM

Tea Break with Poster walk

4.45-6.00 PM

4.45-5.10 PM

Diagnostic evaluation in MDS: Is it all about molecular profiling?

Speaker: Dr. H.P.Pati

Heavy menstrual bleed in teens: Diagnostic challenges.

Speaker: Dr. Jasmina Ahluwalia

Role of FDG-PET in lymphoma.

Speaker: Dr. Aby Abraham

Testing for HIT.

Speaker: Dr. Swati Pai

5.10-5.35 PM

Childhood MDS: Where are we now?

Speaker: Dr. Deepak Bansal

Thrombotic microangiopathy in pregnancy: Is it different?

Speaker: Dr. Avinash K.Singh

Relapsed/refractory HL: Therapeutic options in 2022.

Speaker: Dr. Shuvra Neel Baul

Treatment of HIT.

Speaker: Dr. Suman Pramanik

5.35-6.00 PM

Treatment of Low Risk MDS in 2022.

Speaker: Dr. Chepsy. C. Philip

Anticoagulation in pregnancy.

Speaker: Dr. Naresh Gupta

Follow up of patients with HL.

Speaker: Dr. Sharat Damodar

Management of ITP in adults.

Speaker: Dr. Vinay V Bohara

6.00 PM Onwards

7.00 AM

Walk for Haematology

7.30 AM onwards

REGISTRATION

8.00-8.30 AM

BUMPER QUIZ

8.30-9.00 AM

Session 35 - Dr. Malti Sathe Oration(Hall A)

Chairpersons: Dr. P. K. Gogoi & Dr. Kanjaksha Ghosh

Topic-"Providing molecular diagnostic services for nonmalignant hematological diseases: Trials, tribulations, and satisfactions "

Speaker: Dr. Reena Das

9.00 - 10.15 AM

9.00 - 9.25 AM

Treatment of unfit AML: approvals and ongoing trials

Speaker: Dr. Aniket Bankar

Capillary Electrophoresis: Hope for diagnosis in thalassemia.

Speaker: Dr. Basab Bagchi

Molecular genetics of B cell ALL

Speaker: Dr. Sanjeev K.Gupta

Erythrocyte Alloimmunisation: How to overcome?

Speaker: Dr. Prasun Bhattacharyya

9.25 - 9.50 AM

AML Post (3+7): How to guide the patient and family through the ordeal of further therapy.

Speaker: Dr. Sukanya Gogoi

Thalassemia: Alternatives to blood transfusion.

Speaker: Dr. Baba Inusa

Treatment of the older adult with ALL : Personalized therapy.

Speaker: Dr. Samar Kulkarni

Chronic transfusion therapy in bone marrow failure: Personalized approach.

Speaker: Dr. Soumya Bhattacharya

9.50 - 10.15 AM

Targeted relapse refractory AML.

Speaker: Dr. Gautam Borthakur

Prenatal diagnosis of thalassemia

Speaker: Dr. Anita Nadkarni

How to treat relapsed ALL in older patients?

Speaker: Dr. Pravas Mishra

Management of Haemolytic transfusion reactions.

Speaker: Dr. Anshul Gupta

10.15-10.45 AM

Coffee Break

10.45-12.15 PM

Session 40 - ISHBT-EHA Joint Symposium(Hall A)

Chairpersons: Dr. Shanaz Khodaiji & Dr. Konstanze Dohner

Topic: Acute Myeloid Leukemia

Topic: Towards precision medicine in AML Speaker : Dr. Konstanze Dohner

Topic: Treatment of IDH mutated AML Speaker : Dr. Stephane de Botton

Topic: AML-Challenges in Indian Context Speaker : Dr. Vikram Mathews

12.15-1.00 PM

Sponsored Symposium - 5

By Intas Pharmaceuticals Ltd.

Topic: Role of Romiplostim in Severe Aplastic Anemia

Speaker: Dr. Ganesh Jaishetwar

Topic: Case Based Panel Discussion

Moderator: Dr. Sameer Tulpule

Pannelists: Dr Nishad Dhakate,Dr Saurabh Bhave, Dr Anupam Chakrapani, Dr Seema Bhatwadekar, Dr Mahesh Rajashekaraiah, Dr Santanu Sen, Dr Soumya Bhattacharya, Dr Arun V, Dr. Manas Kalra

Sponsored Symposium - 6

By AstraZeneca

12.15 - 12.45 PM : Topic: Expert discussion on management of HR CLL with Calquence

Speaker & Moderator : Dr. Rahul Naithani

Panelist : Dr Pawan Kumar Singh, Dr Shilpa Bhartia, Dr Kundan Mishra, Dr Sanjeev, Dr Sudeep V, Dr Anshul Gupta

Session 2

12.50 - 1.20 PM : Topic: Management of CLL in 2022 with newer generation BTK inhibitors

Speaker : Dr. Saurabh Bhave

Sponsored Symposium - 7

By Novonordisk

Welcome remarks

Speaker: Dr S Pramanik

Novo Nordisk

Topic: commitment to Rare Blood Disorders

Speaker: Dr. Rinz Paulose

Topic: Changing landscape of haemophilia with EHL factors: unmet needs and guidelines

Speaker: Dr. Sonali Salve

Topic: Driving change with glycopegylated EHL factors: clinical data and real-world experiences in India

Speaker: Dr. Tulika Seth

Closing remarks: Dr S Pramanik

Sponsored Symposium - 8

By Horiba

Topic: Evolving paradigm of hemocytomorphometry- from cell counts to morphology!

Speaker: Dr. Anil Handoo

1.00-2.00 PM

Lunch Break

2.00-3.00 PM

2.00 PM - 2.12 PM

Modulating effects of alpha globin gene mutations in defining the phenotypes of IVS1-5(CC) beta thalassemia patients

Speaker: Dr. Jyoti Shaw

Comparative study of cellular morphology of bone marrow aspiration, bone marrow imprint smear, and bone marrow biopsy in tertiary care centre

Speaker: Dr. Priti Toppo

Whole exome mutation study in triple negative polycythemia- An Indian quest

Speaker: Dr. Harikrishnan P

Unravelling the somatic mutational landscape in myelodysplastic syndrome: A single center experience

Speaker: Dr. Indranil Dey

2.13 PM - 2.24 PM

A limited and economical genotyping panel unravels the molecular genetic basis of beta-thalassemia intermedia in a majority of cases: A study on 256 Indian patients

Speaker: Dr. Namrata Singh

HLA matching profile among transplant eligible patients in Indian scenario

Speaker: Dr. Surbhi Saxena

Study of BCR-ABL1 kinase domain mutation profile: A 10 years experience of a tertiary cancer care center

Speaker: Dr. Debajani Nathi

Mono-Dysplasia score based on automated cell counters- A novel parameter for differentiating reactive monocytosis form haematological malignancies

Speaker: Dr. Priyanka Moule

2.25 PM - 2.36 PM

Clinical profile and impact of viral infections (CMV, EBV & Parvovirus) on pediatric hematoncology patients

Speaker: Dr. Purvaja Kubde

Differentiation of aplastic anaemia from myelodysplastic syndrome using cell population data analysis on SYSMEX XN-9000 automated hematology analyser

Speaker: Dr. Sreya P B

Long-term real-world outcomes of patients with high-risk acute promyelocytic leukemia treated with arsenic trioxide and all trans retinoic acid without chemotherapy

Speaker: Dr. Charanpreet Singh

Clinicopathological and immunophenotypic characteristics of hairy cell leukemia: An institutional experience

Speaker: Dr. Somanath Padhi

2.37 PM - 2.48 PM

Clinical outcomes of allogeneic stem cell transplantation in adolescents and young adults with thalassemia major: A single centre experience.

Speaker: Dr. Mithun Prakash

Sigma metrics in haematology: Are second party controls a better alternative?

Speaker: Dr. Khevna Kansara

Feasibility and safety of using gemtuzumab ozogamicin in the treatment of acute myeloid leukemia: Real world data from a tertiary care cancer center in India

Speaker: Dr. Vinay Anand Guntiboina

Myeloid-derived suppressor cells: A silent foe in precursor B cell acute lymphoblastic leukemia

Speaker: Dr. Mousumi Kar

2.49 PM - 3.00 PM

Assessment of liver fibrosis by fibroscan as a surrogate marker in beta thalassemia major patients.

Speaker: Dr. Sukanya Priyadarshini Mohanty

Performance evaluation of digital cell imaging by SYSMEX DI-60 integrated into automated hematology analyzer system

Speaker: Dr. Debirupa De

Diagnostic Splenectomy: Clinical profile, role and relevance in diagnosis of lymphoma

Speaker: Dr. Nutan Joshi

Study of association between CRLF2 overexpression and post induction MRD status by flow cytometric evaluation in PH-like B-ALL patients.

Speaker: Dr. Vineeta Yadav

3.00-4.15 PM

3:00 - 3:25 PM

Transforming SCD Care in India: Catalyst for Advancing Initiatives in Africa.

Speaker: Dr. Isacc Odame

Risk stratification in CLL.

Speaker: Dr. Shanaz Khodaiji

Genetics of progression from MDS to secondary leukemia.

Speaker: Dr. Neeraj Arora

HLH during initial evaluation: How important is genetics?

Speaker: Dr. Debdatta Basu

3:25 - 3:50 PM

Sickle Cell Pain: Working Towards the Challenge

Speaker: Dr. Kalpana Gupta

Treatment strategies in CLL : Current and future.

Speaker: Dr. Sumit Mitra

MPN transformation to acute leukemia: How to tackle?

Speaker: Dr. Farah Jijina

HLH: Overview of initial management and monitoring.

Speaker: Dr. Uttam Kumar Nath

3:50 - 4:15

Iron metabolism in thalassemia and SCD.

Speaker: Dr. Maitreyee Bhattacharyya

Toxicities of targeted therapies in CLL : How to manage?

Speaker: Dr. Rahul Naithani

ALL after antecedent malignancy: What exactly do we know?

Speaker: Dr. Anupam Chakrapani

HLH: How to treat relapse or refractory disease?

Speaker: Dr. Fouzia

4.15-4.45 PM

Tea Break + Poster walk

4.45-5.45 PM

4:45 - 5:05 PM

AML diagnosis: Is there still a role of morphology and cytochemistry in the era of IPT?

Speaker: Dr. Tejindar Singh

MM: Moving beyond proteosome inhibitors in India.

Speaker: Dr. Pankaj Malhotra

NHL in children: How are they different from those in adults?

Speaker: Dr. Jina Bhattacharyya

Acquired PRCA: Evaluation and treatment

Speaker: Dr. Bhushan Asthana

5:05 - 5:25 PM

Treatment approaches and monitoring of patients of APML.

Speaker: Dr. Prasanth Ganesan

Therapy in AL amyloidosis: Newer options.

Speaker: Dr. Shaji Kumar

Aggressive B cell lymphoma in the elderly: Approach to therapy.

Speaker: Dr. Gaurav Dixit

Anaemia of cancer: How to treat?

Speaker: Dr. Sanjeevan Sharma

5:25 - 5:45 PM

Older patients of AML-How to treat?

Speaker: Dr. Sandeep Saha

Smouldering myeloma: Do we need to treat?

Speaker: Dr. Rajesh Kashyap

Relapsed or refractory lymphomas in the elderly: What should be the goals of care.

Speaker: Dr. Dipanjan Halder

Approach to nutritional anemia.

Speaker: Dr. P.K.Sasidharan

5.45-6.45 PM

Sponsored Symposium - 9

By Roche

Topic : Introduction & Context Setting

Speaker: Dr. Javid Rasool Bhat

Modem Perspectives : Choosing optimal treatment strategy for management of Follicular Lymphoma in 2022,

Case based Discussion

Moderator: Dr. Rahul Naithani

Panellists: Col (Dr) Suman Pramanik,Dr Nataraj KS, Dr Sreeraj Vasudevan,Dr Ganesh Jaishetwar,Dr Nishad Dhakate

Concluding remarks

Speaker: Dr Javid Rasool Bhat

Sponsored Symposium - 10

Astellas Pharmaceuticals

Topic: Epidemiology and Management Paradigm for FLT3+ Acute Myeloid Leukemia

5.45-5.50 PM : Welcome Note-Astellas Medical Team

5.50-5.55 PM : Setting the context-Dr M.B. Agarwal (Chairperson)

5.55-6.15 PM : Epidemiology and diagnostic paradigm for FLT3+ Acute Myeloid Leukemia

Speaker: Dr. Arijit Nag

6.15-6.35 PM : Management Paradigm for FLT3+ Acute Myeloid Leukemia

Speaker: Dr. Anupam Chakrapani

6.35-6.45 PM : Discussion + Q & A

Sponsored Symposium - 11

By Pfizer

Topic : Diagnosis and Prognosis of Haemophilia

Speaker: Dr. Jina Bhattacharya

Topic : Recent Updates in treatment of Relapsed or refractory B cell Adult Acute Lymphoblastic Leukemia

Speaker: Dr. Soumya Mukherjee

Sponsored Symposium - 12

By Sebia

Topic : Capillary Electrophoresis : An advanced Technology for the Screening of Hemoglobinopathies & Thalassemia

Welcome Note : Dr. Mandeep Singh

Topic : Evolution of different technologies

Speaker : Dr. Siddhartha Sharma

Topic : Landscaping of Hemoglobinopathies through CE technology

Speaker : Dr. Arpita Roy Dam

Topic : Instrument Demonstration

Speaker : Dr. Divya Jain

User experience & Quiz

6.45-7.00pm

Tea Break

7.00-8.00 PM

General Body Meeting

8.00 PM Onwards

8.00-9.30 AM

NATIONAL HEMATOLOGY ISHBT QUIZ FINAL

9.30-11.00 AM

Cytomegalovirus reactivation as a risk factor for all-cause mortality in children undergoing hematopoietic stem cell transplantation:experience over two decades from a tertiary referral center in India.

Speaker : Dr. Sohini Chakraborty

Genetic Spectrum of common and rare inherited bleeding disorders in North India: Next generation sequencing-based approach.

Speaker : Dr. Ritika Sharma

Therapy acquired clonal mutations drive a significant subset of early relapses in pediatric B-cell precursor acute lymphoblastic leukemia cases.

Speaker : Dr. Rozy Thakur

Infrared thermography- a point of care tool for detection of subclinical bleed in patients with haemophilia on propylaxis.

Speaker : Dr. Moupali Ghosh

Venetoclax induces autophagy and apoptosis by targeting Stat3/Bcl-2 axis in arsenic trioxide resistant acute promyelocytic leukemia.

Speaker : Dr. Deepshikha Dutta

11.00-11.15 AM

Tea Break

11.15-12.30 PM

Management of Eosinophilia beyond steroids.

Speaker: Dr. Saurav Bhave

Thrombocytosis in OPD setting

Speaker: Dr. Seema Bhatwadekar

Bleeding in neonates.

Speaker: Dr. Pritam Singha Roy

Role of Haematologist during liver transplant.

Speaker:Dr. Abhishek Sharma

Bleeding in the Uremic patients.

Speaker: Dr. Shuvra Neel Baul

Haematological abnormalities in parasitic infections in our country.

Speaker: Dr. Jyoti Kotwal

12.30-1.40 PM

• Thrombosis in high altitude

Speaker: Dr Velu Nair

• Pharmacological correction of G6PD for the management of hemolytic anemia

Speaker: Dr. Shailja Singh

• Advanced diagnostic tools for congenital hemolytic anemia (CHA): New concepts and strategies.

Speaker: Dr. Prabhakar Kedar

12.30 - 1.05 PM
Debate 1 - (15mins +15 mins +5 mins)

Laboratory haematology should be an integral part of Haematology Department

Yes: Dr.Arijit Nag

No: Dr. Siddhesh Kalantri

1.05 - 1.40 PM
Debate 2 - (15mins +15 mins +5 mins)

We cannot do without stem cell transplant in Mantle cell lymphoma

Yes: Dr. Rahul Bhargava

No: Dr. Prantar Chakrabarti

• Abnormal coagulation parameters in the ICU setting

Speaker: Dr. Pankhi Dutta

• Fungal infection in haematological malignancy.

Speaker: Dr. Sonali Mohapatra

• CML in pregnancy.

Speaker: Dr. Sarmila Chandra

Monoclonal gammopathies of clinical significance

Speaker: Dr. Ashutosh Wechalekar

Elderly Myeloma –How to approach?

Speaker: Dr Mukul Agarwal

POEMS-Where we are in 2022?

Speaker: Dr. Sanjeev

1.40 PM Onwards

VALEDICTORY FUNCTION AND PRIZE DISTRIBUTION FOLLOWED BY LUNCH